1 1

Mounjaro 7.5mg KwikPen (Tirzepatide)

Mounjaro 7.5mg KwikPen (Tirzepatide)

Brand Name: Mounjaro®
Origin: ELI LILLY AND COMPANY (Depends on the specific batch/market; approved manufacturing sites include Italy, Spain, France, and Ireland)
Small Orders: Yes/Available
Tags: 7.5mg KwikPen , Appetite Control , Blood Sugar Control , Diabetes Treatment , Eli Lilly , GIP/GLP-1 Receptor Agonist , GLP-1 , Injectable Medicine , KwikPen , Metabolic Health , Mounjaro , Mounjaro 7.5mg , Mounjaro KwikPen , Multi-Dose Pen , Once-Weekly Injection , Pre-Filled Pen , Prescription Medicine , Tirzepatide , Tirzepatide 7.5mg , Tirzepatide Injection , Type 2 Diabetes , Weight Loss , Weight Management
Ver todos los detalles
  • Details
  • Description
Packaging Size: 1 multi-dose pre-filled KwikPen containing 4 doses of 0.6 mL
Strength: 7.5 mg/0.6 mL per dose
Composition: Active substance: tirzepatide. Other ingredients include sodium phosphate dibasic heptahydrate, benzyl alcohol, glycerol, phenol, sodium chloride, sodium hydroxide, hydrochloric acid, and water for injections.
Treatment: Used for type 2 diabetes and, where approved, weight management. It is a GIP/GLP-1 receptor agonist administered once weekly.
Form: Clear, colourless to slightly yellow solution for injection in a multi-dose pre-filled KwikPen
Brand: Mounjaro®
Quantity Unit: 1 pre-filled KwikPen
Manufacturer: Eli Lilly manufacturing network

Mounjaro 7.5 mg KwikPen is a prescription, once-weekly injectable medicine containing tirzepatide, a GIP and GLP-1 receptor agonist. It is used to help improve blood-glucose control in people with type 2 diabetes and, where approved, to support weight management alongside diet and physical activity. Each dose contains 7.5 mg of tirzepatide in 0.6 mL, and each pre-filled KwikPen provides 4 weekly doses (30 mg total tirzepatide per pen).

Active substance: Tirzepatide
Strength: 7.5 mg/0.6 mL per dose
Dosage form: Solution for subcutaneous injection
Pack: 1 multi-dose pre-filled KwikPen containing 4 doses.

Each 7.5 mg KwikPen contains 4 doses, for a total of 30 mg tirzepatide in 2.4 mL.

The official product information lists manufacturing sites in Italy, Spain, France, and Ireland, so the exact origin should be checked on the specific package/batch

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.